Control Bionics (ASX:CBL) Other Gross PPE : A$0.00 Mil (As of Dec. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Control Bionics Other Gross PPE?

Control Bionics's Other Gross PPE for the quarter that ended in Dec. 2024 was A$0.00 Mil.

Control Bionics's quarterly Other Gross PPE increased from Dec. 2023 (A$0.00 Mil) to Jun. 2024 (A$0.59 Mil) but then declined from Jun. 2024 (A$0.59 Mil) to Dec. 2024 (A$0.00 Mil).

Control Bionics's annual Other Gross PPE increased from Jun. 2022 (A$0.36 Mil) to Jun. 2023 (A$0.36 Mil) and increased from Jun. 2023 (A$0.36 Mil) to Jun. 2024 (A$0.59 Mil).

Control Bionics Other Gross PPE Historical Data

The historical data trend for Control Bionics's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Control Bionics Other Gross PPE Chart

Control Bionics Annual Data

Trend

Jun21

Jun22

Jun23

Jun24

Other Gross PPE

0.01

0.36

0.59

Control Bionics Semi-Annual Data
	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Other Gross PPE	Get a 7-Day Free Trial				-	0.36	-	0.59	-

Control Bionics Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.

Control Bionics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Control Bionics Ltd (ASX:CBL) » Definitions » Other Gross PPE

Comparable Companies

Traded in Other Exchanges

N/A

Address

11-13 Pearson Street, Level 4, Cremorne, VIC, AUS, 3121

Website

https://www.controlbionics.com

Control Bionics Ltd is engaged in the healthcare device business. It is involved in developing, commercializing, and selling assistive communications technology systems within the disability sector. Its core systems include NeuroNode Trilogy and NeuroNode3. These systems allow people with speech and movement difficulties to control a computer for speech generation, electronic communications, entertainment, and external control of other devices. Geographically it derives a majority of revenue from North America and has its presence in Australia as well.